Back to mobile site

ThinkEquity Starts Corcept Therapeutics (CORT) at Buy

June 29, 2012 7:17 AM EDT
Get Alerts CORT Hot Sheet
Price: $79.85 +0.18%

Rating Summary:
    7 Buy, 10 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE
ThinkEquity initiates coverage on Corcept Therapeutics (NASDAQ: CORT) with a Buy. PT $7.00.

For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.

Shares of Corcept Therapeutics closed at $4.29 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

ThinkEquity